BioWorld

June 25, 1997

View Archived Issues

Other News to Note

Read More

Correction

Read More

Cambridge NeuroScience Halts Phase III Trial Of Cerestat Over Safety Concerns

Read More

Human Genome Sciences, TIGR Part Company Five Years Early And $38M Shy Of Origin

Read More

IDEC, SmithKline Beecham Suspend Rheumatoid Arthritis Phase III Trial

Read More